There appears to be a drug interaction between hydroxychloroquine and metformin which results in death, according to findings of a study published in *Drug Safety*.

Disproportionality analysis of data from VigiBase, the WHO pharmacovigilance database, was used to investigate a potential a drug interaction between hydroxychloroquine and metformin resulting in fatal outcomes in adults 18−64 years of age. Reporting odds ratios (RORs) were determined for Individual Case Safety Reports (ICSRs) of fatal outcomes reported between 2000 and 2019 in patients receiving hydroxychloroquine (or chloroquine) and metformin compared with those receiving hydroxychloroquine (or chloroquine) alone and metformin alone.

Overall, 52 out of 10 771 ICSRs involving hydroxychloroquine were recorded as fatal outcomes, and 30 of these were described as completed suicide. The ROR for fatal outcomes associated with hydroxychloroquine plus metformin compared with hydroxychloroquine alone was 57.7 (95% CI 23.9, 139.3), and the ROR for fatal outcomes associated with hydroxychloroquine plus metformin compared with metformin alone was 6.0 (95% CI 2.6, 13.8). When suicides were excluded, the ROR for fatal outcomes with hydroxychloroquine plus metformin versus hydroxychloroquine alone was 15.8 (95% CI 2.1, 120.6).

Seven deaths were reported in patients receiving hydroxychloroquine plus metformin, of which six were described as completed suicides, and 15 deaths including eight completed suicides were reported in patients receiving chloroquine. No fatal outcomes were associated with chloroquine plus metformin or other antihyperglycaemic drugs.

\"Our study identified a signal for the association hydroxychloroquine + metformin that appears to be more at risk of fatal outcomes (particularly by completed suicides) than one of the two drugs when given alone,\" concluded the authors. \"From a clinical point of view, our results suggest a warning for metformin-treated diabetic patients receiving hydroxychloroquine, for example as self-medication or in off-label use for COVID-19,\" they said.
